Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · IEX Real-Time Price · USD
5.96
-0.15 (-2.45%)
At close: Apr 19, 2024, 4:00 PM
6.02
+0.06 (1.01%)
After-hours: Apr 19, 2024, 4:25 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $781.83 million as of April 19, 2024. Its market cap has decreased by -59.77% in one year.
Market Cap
781.83M
Enterprise Value
82.50M
1-Year Change
-59.77%
Ranking
Category
Stock Price
$5.96
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.05B to $781.83M, a decrease of -74.32%. That is a compound annual growth rate of -30.35%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 801.50M | -1.61% |
Apr 17, 2024 | 814.60M | -7.86% |
Apr 16, 2024 | 884.10M | -1.33% |
Apr 15, 2024 | 896.00M | -2.84% |
Apr 12, 2024 | 922.20M | -1.40% |
Apr 11, 2024 | 935.30M | 3.34% |
Apr 10, 2024 | 905.10M | -5.61% |
Apr 9, 2024 | 958.90M | 1.66% |
Apr 8, 2024 | 943.20M | 4.21% |
Apr 5, 2024 | 905.10M | -0.87% |
Apr 4, 2024 | 913.00M | -2.52% |
Apr 3, 2024 | 936.60M | -6.06% |
Apr 2, 2024 | 997.00M | -5.24% |
Apr 1, 2024 | 1.05B | -3.37% |
Mar 28, 2024 | 1.09B | 1.72% |
Mar 27, 2024 | 1.07B | 7.79% |
Mar 26, 2024 | 993.00M | 0.53% |
Mar 25, 2024 | 987.80M | -3.34% |
Mar 22, 2024 | 1.02B | -2.74% |
Mar 21, 2024 | 1.05B | 0.25% |
Mar 20, 2024 | 1.05B | 2.56% |
Mar 19, 2024 | 1.02B | 3.87% |
Mar 18, 2024 | 983.80M | -5.67% |
Mar 15, 2024 | 1.04B | -2.69% |
Mar 14, 2024 | 1.07B | -10.62% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Autolus Therapeutics | 835.69M |
89bio | 830.29M |
Definitive Healthcare | 829.24M |
Kyverna Therapeutics | 819.62M |
ARS Pharmaceuticals | 814.47M |
Paragon 28 | 799.38M |
Praxis Precision Medicines | 796.13M |
ALX Oncology Holdings | 789.39M |